| P50 | author | Akiyoshi Takami | Q60971614 |
| P2093 | author name string | Shinji Nakao | |
| | J Luis Espinoza | |
| | Ly Q Trung | |
| P2860 | cites work | NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities | Q40053992 |
| | Resveratrol induces apoptosis of human malignant B cells by activation of caspase-3 and p38 MAP kinase pathways | Q40326791 |
| | Human microRNA-1245 down-regulates the NKG2D receptor in natural killer cells and impairs NKG2D-mediated functions | Q41840058 |
| | Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells | Q46564492 |
| | Resveratrol modulates DNA double-strand break repair pathways in an ATM/ATR-p53- and -Nbs1-dependent manner | Q46824029 |
| | Resveratrol selectively inhibits leukemia cells: a prospective agent for ex vivo bone marrow purging | Q73586568 |
| | The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor | Q24306696 |
| | Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms | Q24648759 |
| | Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias | Q28303057 |
| | Modulation of Akt and ERK1/2 pathways by resveratrol in chronic myelogenous leukemia (CML) cells results in the downregulation of Hsp70 | Q28472533 |
| | Resveratrol prevents EBV transformation and inhibits the outgrowth of EBV-immortalized human B cells | Q28484266 |
| | Therapeutic potential of resveratrol: the in vivo evidence | Q29547413 |
| | Cell cycle checkpoint signaling through the ATM and ATR kinases | Q29617837 |
| | Thermal- and oxidative stress causes enhanced release of NKG2D ligand-bearing immunosuppressive exosomes in leukemia/lymphoma T and B cells | Q33833898 |
| | Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation. | Q34107721 |
| | Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis | Q34316229 |
| | ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease | Q34424253 |
| | Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. | Q34552323 |
| | Resveratrol induces cell cycle arrest and apoptosis in malignant NK cells via JAK2/STAT3 pathway inhibition | Q34571639 |
| | Cancer chemopreventive activity of resveratrol. | Q34697079 |
| | High-throughput genotoxicity assay identifies antioxidants as inducers of DNA damage response and cell death. | Q35887278 |
| | Promiscuity and the single receptor: NKG2D. | Q36900826 |
| | The NKG2D receptor: immunobiology and clinical implications. | Q37056344 |
| | Soluble NKG2D ligands: prevalence, release, and functional impact. | Q37175094 |
| | Beyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy Cells | Q37559284 |
| | Resveratrol and cellular mechanisms of cancer prevention | Q37831924 |
| | Chemoprevention in experimental animals | Q37831932 |
| | ATM protein kinase: the linchpin of cellular defenses to stress | Q37870855 |
| | Resveratrol enhances perforin expression and NK cell cytotoxicity through NKG2D-dependent pathways | Q39750834 |
| | Hydroxyurea upregulates NKG2D ligand expression in myeloid leukemia cells synergistically with valproic acid and potentially enhances susceptibility of leukemic cells to natural killer cell-mediated cytolysis | Q39760172 |
| | Anti-moesin antibodies derived from patients with aplastic anemia stimulate monocytic cells to secrete TNF-alpha through an ERK1/2-dependent pathway. | Q39833116 |
| P433 | issue | 6 | |
| P921 | main subject | leukemia | Q29496 |
| P304 | page(s) | 657-662 | |
| P577 | publication date | 2013-04-26 | |
| P1433 | published in | Cancer Science | Q326125 |
| P1476 | title | Ataxia-telangiectasia mutated kinase-mediated upregulation of NKG2D ligands on leukemia cells by resveratrol results in enhanced natural killer cell susceptibility | |
| P478 | volume | 104 | |